Home > Financial Ratios > BIOCON

BIOCON
EV/Core EBITDA

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 18.4612.4810.8513.9019.85

What is the latest EV/Core EBITDA ratio of BIOCON ?

The latest EV/Core EBITDA ratio of BIOCON is 18.46 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202618.46
Mar202512.48
Mar202410.85
Mar202313.90
Mar202219.85

How is EV/Core EBITDA of BIOCON Trending?

Years EV/Core EBITDA % Change
Mar2026 18.46
47.92
Mar2025 12.48
15.02
Mar2024 10.85
-21.94
Mar2023 13.9
-29.97
Mar2022 19.85 -

Other Financial Ratios of BIOCON


Compare EV/Core EBITDA ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹62,091.6 Cr -2.9% -8.2% 7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr -4% 8.1% 55.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.3% 0.2% 36.6% Stock Analytics
CIPLA ₹109,950.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr -0.2% -4.4% -10.2% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.9%

-8.2%

7.2%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses